Key findings
The study is based on extensive analyses of immune profiles, antibody levels, and disease development in NOD mice, including embryo transfer to B6 females to distinguish the effects of the fetal environment.
* Around 50% lower incidence of type 1 diabetes in NOD mice carried by B6 females
* Similar levels of pancreatic inflammation in both groups, despite differences in disease outcome
* Changes in autoantibodies and increased numbers of regulatory T cells in mice developed in a B6 uterine environment
* Genetic factors and postnatal gut microbiota can be ruled out as main explanations; placental transfer of antibodies is a possible mechanism
